GLT8D1
Glycosyltransferase 8 domain-containing protein 1
Also known as: AD-017, FLJ14611, GL8D1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q68CQ7
- Gene
- GLT8D1
- Ensembl
- ENSG00000016864
- Chromosome
- 3
- Canonical length
- 371 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Centrosome
OverviewNCBI Gene
This gene encodes a member of the glycosyltransferase family. The specific function of this protein has not been determined. Alternative splicing results in multiple transcript variants of this gene [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
371 residues, UniProt reviewed canonical sequence.
>Q68CQ7|GLT8D1
1 MSFRKVNIII LVLAVALFLL VLHHNFLSLS SLLRNEVTDS GIVGPQPIDF VPNALRHAVD
61 GRQEEIPVVI AASEDRLGGA IAAINSIQHN TRSNVIFYIV TLNNTADHLR SWLNSDSLKS
121 IRYKIVNFDP KLLEGKVKED PDQGESMKPL TFARFYLPIL VPSAKKAIYM DDDVIVQGDI
181 LALYNTALKP GHAAAFSEDC DSASTKVVIR GAGNQYNYIG YLDYKKERIR KLSMKASTCS
241 FNPGVFVANL TEWKRQNITN QLEKWMKLNV EEGLYSRTLA GSITTPPLLI VFYQQHSTID
301 PMWNVRHLGS SAGKRYSPQF VKAAKLLHWN GHLKPWGRTA SYTDVWEKWY IPDPTGKFNL
361 IRRYTEISNI KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLT8D1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- liver: 65 nTPM
- pituitary gland: 61 nTPM
- testis: 60 nTPM
- thyroid gland: 60 nTPM
- ovary: 59 nTPM
- fallopian tube: 51 nTPM
Single-cell type
- late primary spermatocytes: 229 nCPM
- fallopian tube ciliated cells: 95 nCPM
- respiratory ciliated cells: 89 nCPM
- extravillous trophoblasts: 86 nCPM
- decidual stromal cells: 83 nCPM
- early primary spermatocytes: 75 nCPM
Immune cell
- basophil: 39 nTPM
- NK-cell: 30 nTPM
- plasmacytoid DC: 23 nTPM
- naive CD4 T-cell: 22 nTPM
- memory CD4 T-cell: 22 nTPM
- eosinophil: 22 nTPM
Brain region
- choroid plexus: 53 nTPM
- white matter: 36 nTPM
- midbrain: 35 nTPM
- hypothalamus: 34 nTPM
- basal ganglia: 33 nTPM
- spinal cord: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GLT8D1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 56 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.62
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLT8D1 as an antibody target. Whether an autoantibody or antibody against GLT8D1 could matter depends on whether native GLT8D1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLT8D1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GLT8D1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...